Jane Glasson and Jack Harkness’s collaboration

Jane Glasson and Jack Harkness’s collaboration joins Jane’s concealed professional life to the novel’s central corporate and ecological crisis. Recruited by Harkness to help develop a nanobot programme, Jane becomes one of the people who helped shape its purpose and its limits. As Harkness moves toward action while she and Filippo Crosetti doubt that the drastic contingency remains necessary, the partnership is recast as a struggle over consent, trust, and who has the authority to decide what counts as a last resort.

Formation and concealed role

For twenty-two years after Jane’s disappearance, the records examined by Ingrid Denner do not identify anyone of Jane’s age and nationality as an employee of Harkness Pharmaceuticals. Ingrid’s investigation eventually broadens to cover self-employed consultants, advisers, and other specialists contracted by the company. That search also fails to find a matching attachment dating back to 1996, although most contracts were short and few lasted more than two years. The absence of Jane from the ordinary employment lists therefore does not establish that she had no connection to Harkness; instead, it forms part of the mystery surrounding how she worked for the company.

Jane’s connection becomes clearer when she is identified as specialist contractor 55, the person Ingrid is due to meet with Filippo Crosetti in Zug. The planned discussion concerns contra-indications as well as the contractor’s role. Jane works for, or in conjunction with, Harkness and Crosetti, but the evidence does not reduce her position to a conventional employee relationship. The file’s contractor designation, together with the earlier failure to find her in employee records, marks her work as professionally connected to the company yet difficult to trace through its standard personnel channels.

The nanobot programme

The collaboration’s defining purpose is revealed through Crosetti’s account of the project. Harkness, Jane, and Crosetti share the stated aim of preventing an impending ecological catastrophe. Harkness entered pharmaceuticals because he calculated that the industry could provide a means to pursue that aim; he recruited Jane, then Crosetti, to develop a programme intended to produce the result they believed the world needed. Jane is therefore not presented merely as someone who later encounters Harkness’s plans: she is part of the small group that helped create them.

The programme’s reach depends on the ordinary circulation of Harkness Pharmaceuticals products. Crosetti explains that people who have used the company’s drugs or cosmetics during the preceding five years may carry nanobots in their bloodstream. He includes products used in beauty treatments, headache remedies, anti-malarials, and pain relief, as well as Elixtris and Fenextris. Exposure also extends, in his account, to food grown using the company’s pesticides and meat from animals treated with its antibiotics. The nanobots are continually replaced as production continues, making the project a covert, widespread intervention rather than a device confined to a laboratory or a small test group.

That scale gives Jane and Harkness’s association consequences beyond their own professional circle. Their work helps place nanotechnology inside products used in everyday life, while the project’s stated environmental purpose sits in tension with the breadth of the means. Crosetti describes the nanobots as initially symptomless and says they eventually leave the body only to be replaced by more. The account establishes the programme’s distribution and its intended stakes, while leaving the decisive effects beyond the point at which this evidence breaks off.

A shared limit and a disputed contingency

The partners do not agree that the project should proceed under every circumstance. Crosetti recalls that he and Jane repeatedly argued through whether they should continue, and that Harkness had been told from the beginning that the intervention was acceptable only as a last resort. Crosetti says that this condition no longer seems to him to be met: he and Jane do not believe the drastic measure is still necessary. Jane’s role in the collaboration thus includes resistance to an outcome that the original project’s own terms were meant to constrain.

The disagreement intensifies while Harkness is absent and Crosetti tries to interpret his actions. Crosetti suspects Harkness has made a move because he is no longer willing to wait for the others to decide whether the programme should ever go ahead. Jane challenges the certainty of that explanation. She does not confirm Crosetti’s reading of Harkness’s intentions, and the exchange leaves the difference between what Crosetti fears and what Jane knows unresolved.

Crosetti also worries that Harkness could evade their agreement without openly breaking it: he might arrange for someone else to act, someone who did not understand the limits they had discussed. This fear makes their disagreement more than a dispute over the project’s scientific or environmental rationale. The question is whether the safeguards embedded in their understanding can hold if Harkness controls the decision and can act through others. Jane, by contrast, maintains that Harkness is a man of his word. Her confidence is specifically about his keeping the agreement; it does not mean that she supports proceeding with the programme now.

Partnership under pressure

The conversation exposes how far the collaboration has shifted from collective planning toward suspicion. Crosetti’s alarm is sharpened by the timing: Harkness knows that he is away from the laboratory because of Ingrid Denner, and Crosetti interprets Harkness’s apparent initiative as an effort to act before the others can stop the plan. Jane answers with uncertainty rather than a rival explanation, and she urges Crosetti not to treat his inference as established fact. Their exchange shows a division between Crosetti’s growing conviction that Harkness is moving against them and Jane’s effort to keep suspicion distinct from proof.

Their shared history nevertheless gives Jane’s reassurance weight. She knows the agreement as one of the project’s original conditions, and Crosetti’s fear that Harkness will exploit its wording assumes that the three men and women had a common understanding to begin with. Jane’s position is consequently double-edged: she recognizes that the project has become dangerous enough to reconsider, yet still invokes Harkness’s promise as a reason to believe he will not simply override their terms. The partnership is sustained by a prior commitment even as the possibility of unilateral action threatens to make that commitment ineffective.

Significance

Jane and Harkness’s collaboration links the novel’s hidden employment trail to its largest moral conflict. The contractor records help reveal that Jane’s disappearance from ordinary public life has not meant an absence from consequential work; she has been involved in a programme developed inside Harkness’s pharmaceutical enterprise. The same project that promised a response to ecological destruction depends on distributing nanobots through medicines, cosmetics, agricultural chemicals, and animal antibiotics, extending the collaborators’ decisions into the lives of millions.

The relationship is not simply one of employer and recruit. Harkness brought Jane into a programme whose aims and limits she helped establish, and her later opposition to proceeding reflects that prior participation rather than detachment from it. Her trust in his word collides with Crosetti’s fear that Harkness can arrange for the plan to continue without technically violating their agreement. In that conflict, the collaboration’s central weakness becomes visible: shared authorship and a promise may provide an ethical boundary, but they do not guarantee shared control over what happens next.